{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:26:13Z","timestamp":1792466773303,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007397","name":"Charles University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007397","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This comprehensive study provides insight into the antibacterial action of a recently published 2-chloro-\n                    <jats:italic>N<\/jats:italic>\n                    -(oxazol-2-yl)isonicotinamide (AB15), intending to assess its potential as a candidate adjuvant molecule to support existing antibacterial drugs. Within the determination of the antibacterial effect, a promising activity against a member of the ESKAPE group with reduced treatment options, biofilm producer,\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    , was recognized (MIC of AB15 ranged from 15.63 to 62.5 \u00b5M). In addition, AB15 exhibited bactericidal activity and non\/low-toxicity\n                    <jats:italic>in vitro<\/jats:italic>\n                    (IC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009&gt;\u20091000 \u00b5M using HK-2 cells) and\n                    <jats:italic>in vivo<\/jats:italic>\n                    (LD\n                    <jats:sub>50<\/jats:sub>\n                    \u2009&gt;\u2009500\u00a0mg\/kg of body weight of the\n                    <jats:italic>Galleria mellonella<\/jats:italic>\n                    larvae, for both intra-hemocoel and per oral administration routes). Checkerboard assay revealed additive and synergistic interactions of AB15 and last-resort antibiotic drug, colistin (CST). Moreover, attention was also given to a frequently overlooked antibiofilm activity \u2014 the ability to suppress bacterial dissemination from microbial biofilms, and parameter MBDC (minimum biofilm dissemination concentration) was introduced. The study of the antibiofilm activity of AB15 and CST, both acting individually, or in AB15\u2009+\u2009CST combination, revealed that AB15 has significant potential to suppress bacterial dissemination from biofilm formed by a clinical isolate\n                    <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                    and that it contributes to this effect when combined with CST. Finally, AB15\u2009+\u2009CST combination demonstrated significantly greater biocompatibility towards human erythrocytes than CST acting individually at an equivalent antibiofilm-effective concentration. The role of AB15 as a promising adjuvant molecule to CST is also supported by its distinct mechanism of action, which reduces the risk of antimicrobial resistance emergence. To conclude, AB15 exhibits several essential attributes that support its designation as a promising antibiotic adjuvant.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s00430-025-00854-y","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:01:15Z","timestamp":1758265275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A new bactericidal chlorinated derivative containing 2-aminooxazole potentiates antibacterial action of colistin against multidrug-resistant acinetobacter baumannii"],"prefix":"10.1007","volume":"214","author":[{"given":"Ad\u00e9la","family":"Diepoltov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria Elzbieta","family":"Nawrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Jan\u010fourek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Juh\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"B\u00e1rta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavl\u00edna","family":"V\u00e1vrov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod Sukanth Kumar","family":"Pallabothula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul\u00edna","family":"Dud\u00e1\u0161ov\u00e1-Hatokov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Vejsov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora","family":"Voxov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"\u00d6sterreicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"\u0160t\u011brbov\u00e1-Kova\u0159\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Nachtigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-7767","authenticated-orcid":false,"given":"Kl\u00e1ra","family":"Kone\u010dn\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"854_CR1","unstructured":"WHO. Antimicrobial Resistance (2023) The World Health Organization. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antibiotic-resistance"},{"key":"854_CR2","unstructured":"CDC (2018) Antibiotic resistance: a global threat: centers for disease control and prevention. Available from: https:\/\/www.cdc.gov\/drugresistance\/solutions-initiative\/stories\/ar-global-threat.html"},{"issue":"6","key":"854_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1177\/2042098614554919","volume":"5","author":"C Llor","year":"2014","unstructured":"Llor C, Bjerrum L (2014) Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf 5(6):229\u2013241. https:\/\/doi.org\/10.1177\/2042098614554919","journal-title":"Ther Adv Drug Saf"},{"issue":"1","key":"854_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227139","volume":"15","author":"M Serra-Burriel","year":"2020","unstructured":"Serra-Burriel M, Keys M, Campillo-Artero C, Agodi A, Barchitta M, Gikas A, Palos C, Lopez-Casasnovas G (2020) Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: systematic review and meta-analysis. PLoS ONE 15(1):e0227139. https:\/\/doi.org\/10.1371\/journal.pone.0227139","journal-title":"PLoS ONE"},{"issue":"10014","key":"854_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S0140-6736(15)00473-0","volume":"387","author":"AH Holmes","year":"2016","unstructured":"Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ (2016) Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387(10014):176\u2013187. https:\/\/doi.org\/10.1016\/S0140-6736(15)00473-0","journal-title":"Lancet"},{"key":"854_CR6","unstructured":"WHO (2017) Who publishes list of bacteria for which new antibiotics are urgently needed: The World Health Organization. Available from: https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed"},{"key":"854_CR7","unstructured":"WHO (2024) WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance: The World Health Organization. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240093461"},{"key":"854_CR8","unstructured":"WHO (2025) Global research agenda for antimicrobial resistance in human health: the World Health Organization. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240102309"},{"issue":"3","key":"854_CR9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","volume":"4","author":"WC Reygaert","year":"2018","unstructured":"Reygaert WC (2018) An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol 4(3):482\u2013501. https:\/\/doi.org\/10.3934\/microbiol.2018.3.482","journal-title":"AIMS Microbiol"},{"issue":"8","key":"854_CR10","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2217\/fmb.14.64","volume":"9","author":"SJ McConoughey","year":"2014","unstructured":"McConoughey SJ, Howlin R, Granger JF, Manring MM, Calhoun JH, Shirtliff M, Kathju S, Stoodley P (2014) Biofilms in periprosthetic orthopedic infections. Future Microbiol 9(8):987\u20131007. https:\/\/doi.org\/10.2217\/fmb.14.64","journal-title":"Future Microbiol"},{"issue":"4","key":"854_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/jemt.22344","volume":"77","author":"PR De Souza","year":"2014","unstructured":"De Souza PR, De Andrade D, Cabral DB, Watanabe E (2014) Endotracheal tube biofilm and ventilator-associated pneumonia with mechanical ventilation. Microsc Res Tech 77(4):305\u2013312. https:\/\/doi.org\/10.1002\/jemt.22344","journal-title":"Microsc Res Tech"},{"issue":"4","key":"854_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/apm.12665","volume":"125","author":"M Gominet","year":"2017","unstructured":"Gominet M, Compain F, Beloin C, Lebeaux D (2017) Central venous catheters and biofilms: where do we stand in 2017? APMIS 125(4):365\u2013375. https:\/\/doi.org\/10.1111\/apm.12665","journal-title":"APMIS"},{"key":"854_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1874285801711010053","volume":"11","author":"S Singh","year":"2017","unstructured":"Singh S, Singh SK, Chowdhury I, Singh R (2017) Understanding the mechanism of bacterial biofilms resistance to antimicrobial agents. Open Microbiol J 11:53\u201362. https:\/\/doi.org\/10.2174\/1874285801711010053","journal-title":"Open Microbiol J"},{"key":"854_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00181-19","author":"DMP de Oliveira","year":"2020","unstructured":"de Oliveira DMP, Forde BM, Kidd TJ, Harris PNA, Schembri MA, Beatson SA, Paterson DL, Walker MJ (2020) Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. https:\/\/doi.org\/10.1128\/CMR.00181-19","journal-title":"Clin Microbiol Rev"},{"key":"854_CR15","doi-asserted-by":"publisher","first-page":"2475067","DOI":"10.1155\/2016\/2475067","volume":"2016","author":"S Santajit","year":"2016","unstructured":"Santajit S, Indrawattana N (2016) Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed Res Int 2016:2475067. https:\/\/doi.org\/10.1155\/2016\/2475067","journal-title":"Biomed Res Int"},{"key":"854_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13756-019-0533-3","volume":"8","author":"D Sharma","year":"2019","unstructured":"Sharma D, Misba L, Khan AU (2019) Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control 8:76. https:\/\/doi.org\/10.1186\/s13756-019-0533-3","journal-title":"Antimicrob Resist Infect Control"},{"issue":"5","key":"854_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18051077","volume":"18","author":"EG Di Domenico","year":"2017","unstructured":"Di Domenico EG, Farulla I, Prignano G, Gallo MT, Vespaziani M, Cavallo I, Sperduti I, Pontone M, Bordignon V, Cilli L, De Santis A, Di Salvo F, Pimpinelli F, Lesnoni La Parola I, Toma L, Ensoli F (2017) Biofilm is a major virulence determinant in bacterial colonization of chronic skin ulcers independently from the multidrug resistant phenotype. Int J Mol Sci 18(5):1. https:\/\/doi.org\/10.3390\/ijms18051077","journal-title":"Int J Mol Sci"},{"issue":"11","key":"854_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000213","volume":"4","author":"H Mulcahy","year":"2008","unstructured":"Mulcahy H, Charron-Mazenod L, Lewenza S (2008) Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog 4(11):e1000213. https:\/\/doi.org\/10.1371\/journal.ppat.1000213","journal-title":"PLoS Pathog"},{"issue":"36","key":"854_CR19","doi-asserted-by":"publisher","first-page":"22684","DOI":"10.1021\/acsomega.0c02294","volume":"5","author":"Y Li","year":"2020","unstructured":"Li Y, Xiao P, Wang Y, Hao Y (2020) Mechanisms and control measures of mature biofilm resistance to antimicrobial agents in the clinical context. ACS Omega 5(36):22684\u201322690. https:\/\/doi.org\/10.1021\/acsomega.0c02294","journal-title":"ACS Omega"},{"key":"854_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00070","volume":"5","author":"SM Amato","year":"2014","unstructured":"Amato SM, Fazen CH, Henry TC, Mok WW, Orman MA, Sandvik EL, Volzing KG, Brynildsen MP (2014) The role of metabolism in bacterial persistence. Front Microbiol 5:70. https:\/\/doi.org\/10.3389\/fmicb.2014.00070","journal-title":"Front Microbiol"},{"issue":"2","key":"854_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10541-005-0111-6","volume":"70","author":"K Lewis","year":"2005","unstructured":"Lewis K (2005) Persister cells and the riddle of biofilm survival. Biochemistry (Mosc) 70(2):267\u2013274. https:\/\/doi.org\/10.1007\/s10541-005-0111-6","journal-title":"Biochemistry (Mosc)"},{"key":"854_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9040205","author":"R Vazquez-Lopez","year":"2020","unstructured":"Vazquez-Lopez R, Solano-Galvez SG, Juarez Vignon-Whaley JJ, Abello Vaamonde JA, Padro Alonzo LA, Rivera Resendiz A, Muleiro Alvarez M, Vega Lopez EN, Franyuti-Kelly G, Alvarez-Hernandez DA, Moncaleano Guzman V, Juarez Banuelos JE, Marcos Felix J, Gonzalez Barrios JA, Barrientos Fortes T (2020) Acinetobacter baumannii resistance: a real challenge for clinicians. Antibiotics. https:\/\/doi.org\/10.3390\/antibiotics9040205","journal-title":"Antibiotics"},{"key":"854_CR23","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.2147\/IDR.S309912","volume":"14","author":"L Chen","year":"2021","unstructured":"Chen L, Yu K, Chen L, Zheng X, Huang N, Lin Y, Jia H, Liao W, Cao J, Zhou T (2021) Synergistic activity and biofilm formation effect of colistin combined with PFK-158 against Colistin-resistant gram-negative bacteria. Infect Drug Resist 14:2143\u20132154. https:\/\/doi.org\/10.2147\/IDR.S309912","journal-title":"Infect Drug Resist"},{"issue":"1","key":"854_CR24","doi-asserted-by":"publisher","first-page":"8763","DOI":"10.1038\/s41598-022-12829-7","volume":"12","author":"B Nishimura","year":"2022","unstructured":"Nishimura B, Escalante J, Tuttobene MR, Subils T, Mezcord V, Pimentel C, Georgeos N, Pasteran F, Rodriguez C, Sieira R, Actis LA, Tolmasky ME, Bonomo RA, Ramirez MS (2022) Acinetobacter baumannii response to cefiderocol challenge in human urine. Sci Rep 12(1):8763. https:\/\/doi.org\/10.1038\/s41598-022-12829-7","journal-title":"Sci Rep"},{"key":"854_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235844","author":"G Annunziato","year":"2019","unstructured":"Annunziato G (2019) Strategies to overcome antimicrobial resistance (AMR) making use of non-essential target inhibitors: a review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20235844","journal-title":"Int J Mol Sci"},{"key":"854_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050580","author":"M Juhas","year":"2022","unstructured":"Juhas M, Bachtikova A, Nawrot DE, Hatokova P, Pallabothula VSK, Diepoltova A, Jandourek O, Barta P, Konecna K, Paterova P, Sestak V, Zitko J (2022) Improving antimicrobial activity and physico-chemical properties by isosteric replacement of 2-aminothiazole with 2-aminooxazole. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph15050580","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"854_CR27","doi-asserted-by":"publisher","first-page":"O255","DOI":"10.1111\/1469-0691.12373","volume":"20","author":"E Matuschek","year":"2014","unstructured":"Matuschek E, Brown DF, Kahlmeter G (2014) Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect 20(4):O255\u2013O266. https:\/\/doi.org\/10.1111\/1469-0691.12373","journal-title":"Clin Microbiol Infect"},{"key":"854_CR28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2003.00790.x","author":"C Hasselmann","year":"2003","unstructured":"Hasselmann C, Microbiology ESC (2003) Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infec. https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00790.x","journal-title":"Clin Microbiol Infec"},{"issue":"1","key":"854_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1128\/AAC.01735-12","volume":"57","author":"J Nowakowska","year":"2013","unstructured":"Nowakowska J, Griesser HJ, Textor M, Landmann R, Khanna N (2013) Antimicrobial properties of 8-hydroxyserrulat-14-en-19-oic acid for treatment of implant-associated infections. Antimicrob Agents Chemother 57(1):333\u2013342. https:\/\/doi.org\/10.1128\/AAC.01735-12","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"854_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/jee\/29.5.870","volume":"29","author":"MH Haydak","year":"1936","unstructured":"Haydak MH (1936) Value of foods other than pollen in nutrition of the honeybee. J Econ Entomol 29(5):870\u2013877. https:\/\/doi.org\/10.1093\/jee\/29.5.870","journal-title":"J Econ Entomol"},{"key":"854_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12575-019-0106-0","volume":"21","author":"L Thieme","year":"2019","unstructured":"Thieme L, Hartung A, Tramm K, Klinger-Strobel M, Jandt KD, Makarewicz O, Pletz MW (2019) MBEC versus MBIC: the lack of differentiation between biofilm reducing and inhibitory effects as a current problem in biofilm methodology. Biol Proced Online 21:18. https:\/\/doi.org\/10.1186\/s12575-019-0106-0","journal-title":"Biol Proced Online"},{"key":"854_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MB-0015-2014","author":"N Barraud","year":"2015","unstructured":"Barraud N, Kjelleberg S, Rice SA (2015) Dispersal from microbial biofilms. Microbiol Spectr. https:\/\/doi.org\/10.1128\/microbiolspec.MB-0015-2014","journal-title":"Microbiol Spectr"},{"issue":"10","key":"854_CR33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41579-022-00767-0","volume":"20","author":"K Sauer","year":"2022","unstructured":"Sauer K, Stoodley P, Goeres DM, Hall-Stoodley L, Burmolle M, Stewart PS, Bjarnsholt T (2022) The biofilm life cycle: expanding the conceptual model of biofilm formation. Nat Rev Microbiol 20(10):608\u2013620. https:\/\/doi.org\/10.1038\/s41579-022-00767-0","journal-title":"Nat Rev Microbiol"},{"key":"854_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032914","author":"IP Saebo","year":"2023","unstructured":"Saebo IP, Bjoras M, Franzyk H, Helgesen E, Booth JA (2023) Optimization of the hemolysis assay for the assessment of cytotoxicity. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24032914","journal-title":"Int J Mol Sci"},{"key":"854_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.btre.2014.07.005","volume":"4","author":"D Boehm","year":"2014","unstructured":"Boehm D, Bell A (2014) Simply red: a novel spectrophotometric erythroid proliferation assay as a tool for erythropoiesis and erythrotoxicity studies. Biotechnol Rep (Amst) 4:34\u201341. https:\/\/doi.org\/10.1016\/j.btre.2014.07.005","journal-title":"Biotechnol Rep (Amst)"},{"key":"854_CR36","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:42717","journal-title":"Sci Rep"},{"issue":"11","key":"854_CR37","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina A, Zoete V (2016) A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11(11):1117\u20131121. https:\/\/doi.org\/10.1002\/cmdc.201600182","journal-title":"ChemMedChem"},{"issue":"10","key":"854_CR38","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1021\/jm700967e","volume":"51","author":"R O'Shea","year":"2008","unstructured":"O\u2019Shea R, Moser HE (2008) Physicochemical properties of antibacterial compounds: implications for drug discovery. J Med Chem 51(10):2871\u20132878. https:\/\/doi.org\/10.1021\/jm700967e","journal-title":"J Med Chem"},{"issue":"W1","key":"854_CR39","doi-asserted-by":"publisher","first-page":"W115","DOI":"10.1093\/nar\/gkac313","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, Tian S, Allen D, Oler E, Peters H, Lui VW, Gautam V, Djoumbou-Feunang Y, Greiner R, Metz TO (2022) BioTransformer 3.0-a web server for accurately predicting metabolic transformation products. Nucl Acids Res 50(W1):W115\u2013W123. https:\/\/doi.org\/10.1093\/nar\/gkac313","journal-title":"Nucl Acids Res"},{"key":"854_CR40","unstructured":"Hu W, Lv F, Tang Y, Chen C, Wei J, Dong S, Quian Y (2017) Spiro three-membered ring, spiro five-membered ring peptide deformylase inhibitor and use thereof in antibacteria and anti-tumor. CN 107362162"},{"key":"854_CR41","unstructured":"Yamaguchi T, Itoh, K., Hirano, T., Shimabara, R., Kawakubo, Y., Sato, M., Yamashita, J., Yazaki, A., Ueshima, T (2018) Preparation of pyridone-carboxylic acid derivatives as antitumor agents WO2018174266"},{"key":"854_CR42","unstructured":"Deangelis AJ, Feng Z (2022) Preparation of bicyclic amides for controlling invertebrate pests 2:WO2022192224"},{"key":"854_CR43","unstructured":"Bleicher K, Mutel V, Vieira E, Wichmann J, Woltering TJ (2000) Preparation of carbamic acid derivatives and evaluation of their use as metabotropic glutamate receptor ligands. WO2000063166"},{"issue":"5","key":"854_CR44","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.5012\/bkcs.2010.31.5.1270","volume":"31","author":"BJ Kim","year":"2010","unstructured":"Kim BJ, Kim J, Kim YK, Choi SY, Choo HYP (2010) Synthesis of benzoxazole amides as novel antifungal agents against malassezia furfur. B Korean Chem Soc 31(5):1270\u20131274. https:\/\/doi.org\/10.5012\/bkcs.2010.31.5.1270","journal-title":"B Korean Chem Soc"},{"key":"854_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112898","volume":"209","author":"D Li","year":"2021","unstructured":"Li D, Liu C, Jiang X, Lin Y, Zhang J, Li Y, You X, Jiang W, Chen M, Xu Y, Si S (2021) Design, synthesis, and evaluation of substituted 2-acylamide-1,3-benzo[d]zole analogues as agents against MDR- and XDR-MTB. Eur J Med Chem 209:112898. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112898","journal-title":"Eur J Med Chem"},{"issue":"3","key":"854_CR46","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1080\/10426500902893209","volume":"185","author":"MM Hemdan","year":"2010","unstructured":"Hemdan MM (2010) Synthesis and antimicrobial activities of some heterocyclic systems from 2-furoyl isothiocyanate. Phosphorus Sulfur 185(3):620\u2013627. https:\/\/doi.org\/10.1080\/10426500902893209","journal-title":"Phosphorus Sulfur"},{"key":"854_CR47","unstructured":"Yamamori TN, Ishizuka K, Sakai NK (2001) InventorAmides as apolipoprotein A-I expression stimulators"},{"issue":"6","key":"854_CR48","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/cbdd.13678","volume":"95","author":"MM Trush","year":"2020","unstructured":"Trush MM, Kovalishyn V, Hodyna D, Golovchenko OV, Chumachenko S, Tetko IV, Brovarets VS, Metelytsia L (2020) In silico and in vitro studies of a number PILs as new antibacterials against MDR clinical isolate Acinetobacter baumannii. Chem Biol Drug Des 95(6):624\u2013630. https:\/\/doi.org\/10.1111\/cbdd.13678","journal-title":"Chem Biol Drug Des"},{"key":"854_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2020.127718","volume":"32","author":"M Haroun","year":"2021","unstructured":"Haroun M, Tratrat C, Petrou A, Geronikaki A, Ivanov M, Ciric A, Sokovic M (2021) 2-aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: synthesis, biological evaluation and molecular docking studies. Bioorg Med Chem Lett 32:127718. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127718","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"854_CR50","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1021\/acsmedchemlett.0c00173","volume":"11","author":"E Azzali","year":"2020","unstructured":"Azzali E, Girardini M, Annunziato G, Pavone M, Vacondio F, Mori G, Pasca MR, Costantino G, Pieroni M (2020) 2-aminooxazole as a novel privileged scaffold in antitubercular medicinal chemistry. ACS Med Chem Lett 11(7):1435\u20131441. https:\/\/doi.org\/10.1021\/acsmedchemlett.0c00173","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"854_CR51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4161\/viru.22493","volume":"3","author":"JC Junqueira","year":"2012","unstructured":"Junqueira JC (2012) Galleria mellonella as a model host for human pathogens. Virulence 3(6):474\u2013476. https:\/\/doi.org\/10.4161\/viru.22493","journal-title":"Virulence"},{"issue":"1","key":"854_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/21505594.2017.1382799","volume":"9","author":"AM Borman","year":"2018","unstructured":"Borman AM (2018) Of mice and men and larvae: Galleria mellonella to model the early host-pathogen interactions after fungal infection. Virulence 9(1):9\u201312. https:\/\/doi.org\/10.1080\/21505594.2017.1382799","journal-title":"Virulence"},{"issue":"1","key":"854_CR53","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1186\/s13104-017-2757-8","volume":"10","author":"K Ignasiak","year":"2017","unstructured":"Ignasiak K, Maxwell A (2017) Galleria mellonella (greater wax moth) larvae as a model for antibiotic susceptibility testing and acute toxicity trials. BMC Res Notes 10(1):428. https:\/\/doi.org\/10.1186\/s13104-017-2757-8","journal-title":"BMC Res Notes"},{"issue":"10","key":"854_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11101092","volume":"11","author":"LI Uzairue","year":"2022","unstructured":"Uzairue LI, Rabaan AA, Adewumi FA, Okolie OJ, Folorunso JB, Bakhrebah MA, Garout M, Alfouzan WA, Halwani MA, Alamri AA, Halawani SA, Alshahrani FS, Hasan A, Mutair AA, Alhumaid S, Etafo J, Utip I, Odoh IM, Uwaezuoke NS (2022) Global prevalence of colistin resistance in Klebsiella pneumoniae from bloodstream infection: a systematic review and meta-analysis. Pathogens 11(10):1092. https:\/\/doi.org\/10.3390\/pathogens11101092","journal-title":"Pathogens"},{"issue":"1","key":"854_CR55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12941-022-00520-8","volume":"21","author":"N Narimisa","year":"2022","unstructured":"Narimisa N, Goodarzi F, Bavari S (2022) Prevalence of colistin resistance of Klebsiella pneumoniae isolates in Iran: a systematic review and meta-analysis. Ann Clin Microbiol Antimicrob 21(1):29. https:\/\/doi.org\/10.1186\/s12941-022-00520-8","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"1","key":"854_CR56","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1080\/22221751.2022.2036078","volume":"11","author":"X Liu","year":"2022","unstructured":"Liu X, Wu Y, Zhu Y, Jia P, Li X, Jia X, Yu W, Cui Y, Yang R, Xia W, Xu Y, Yang Q (2022) Emergence of colistin-resistant hypervirulent Klebsiella pneumoniae (CoR-HvKp) in China. Emerg Microbes Infect 11(1):648\u2013661. https:\/\/doi.org\/10.1080\/22221751.2022.2036078","journal-title":"Emerg Microbes Infect"},{"key":"854_CR57","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00873-18","author":"T Brennan-Krohn","year":"2018","unstructured":"Brennan-Krohn T, Pironti A, Kirby JE (2018) Synergistic activity of colistin-containing combinations against colistin-resistant Enterobacteriaceae. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00873-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"854_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270908","volume":"17","author":"MM Almutairi","year":"2022","unstructured":"Almutairi MM (2022) Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates. PLoS ONE 17(7):e0270908. https:\/\/doi.org\/10.1371\/journal.pone.0270908","journal-title":"PLoS ONE"},{"issue":"1","key":"854_CR59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1099\/jmm.0.000872","volume":"68","author":"MAF Khalil","year":"2019","unstructured":"Khalil MAF, Moawad SS, Hefzy EM (2019) In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model. J Med Microbiol 68(1):52\u201359. https:\/\/doi.org\/10.1099\/jmm.0.000872","journal-title":"J Med Microbiol"},{"key":"854_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113239","author":"C Huang","year":"2022","unstructured":"Huang C, Chen I, Tang T (2022) Colistin monotherapy versus colistin plus meropenem combination therapy for the treatment of multidrug-resistant Acinetobacter baumannii infection: a meta-analysis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11113239","journal-title":"J Clin Med"},{"issue":"3","key":"854_CR61","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/cid\/cit253","volume":"57","author":"E Durante-Mangoni","year":"2013","unstructured":"Durante-Mangoni E, Signoriello G, Andini R, Mattei A, De Cristoforo M, Murino P, Bassetti M, Malacarne P, Petrosillo N, Galdieri N, Mocavero P, Corcione A, Viscoli C, Zarrilli R, Gallo C, Utili R (2013) Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. Clin Infect Dis 57(3):349\u2013358. https:\/\/doi.org\/10.1093\/cid\/cit253","journal-title":"Clin Infect Dis"},{"issue":"9","key":"854_CR62","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1586\/14787210.2013.827881","volume":"11","author":"JM Pogue","year":"2013","unstructured":"Pogue JM, Kaye KS (2013) Is there really no benefit to combination therapy with colistin? Expert Rev Anti-Infect Ther 11(9):881\u2013884. https:\/\/doi.org\/10.1586\/14787210.2013.827881","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"854_CR63","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-210787","author":"A Nigam","year":"2015","unstructured":"Nigam A, Kumari A, Jain R, Batra S (2015) Colistin neurotoxicity: revisited. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2015-210787","journal-title":"BMJ Case Rep"},{"issue":"7","key":"854_CR64","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","volume":"71","author":"A Ordooei Javan","year":"2015","unstructured":"Ordooei Javan A, Shokouhi S, Sahraei Z (2015) A review on colistin nephrotoxicity. Eur J Clin Pharmacol 71(7):801\u2013810. https:\/\/doi.org\/10.1007\/s00228-015-1865-4","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"854_CR65","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/0974-777X.68538","volume":"2","author":"V Manchanda","year":"2010","unstructured":"Manchanda V, Sanchaita S, Singh N (2010) Multidrug resistant acinetobacter. J Glob Infect Dis 2(3):291\u2013304. https:\/\/doi.org\/10.4103\/0974-777X.68538","journal-title":"J Glob Infect Dis"},{"key":"854_CR66","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.2147\/IDR.S332051","volume":"14","author":"A Gedefie","year":"2021","unstructured":"Gedefie A, Demsis W, Ashagrie M, Kassa Y, Tesfaye M, Tilahun M, Bisetegn H, Sahle Z (2021) Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review. Infect Drug Resist 14:3711\u20133719. https:\/\/doi.org\/10.2147\/IDR.S332051","journal-title":"Infect Drug Resist"},{"key":"854_CR67","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.2147\/IDR.S169894","volume":"11","author":"EC Eze","year":"2018","unstructured":"Eze EC, Chenia HY, El Zowalaty ME (2018) Acinetobacter baumannii biofilms: effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments. Infect Drug Resist 11:2277\u20132299. https:\/\/doi.org\/10.2147\/IDR.S169894","journal-title":"Infect Drug Resist"},{"issue":"8","key":"854_CR68","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovic","year":"2007","unstructured":"Stepanovic S, Vukovic D, Hola V, Di Bonaventura G, Djukic S, Cirkovic I, Ruzicka F (2007) Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 115(8):891\u2013899. https:\/\/doi.org\/10.1111\/j.1600-0463.2007.apm_630.x","journal-title":"APMIS"},{"key":"854_CR69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1476-0711-8-28","volume":"8","author":"RK Pettit","year":"2009","unstructured":"Pettit RK, Weber CA, Pettit GR (2009) Application of a high throughput alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms. Ann Clin Microbiol Antimicrob 8:28. https:\/\/doi.org\/10.1186\/1476-0711-8-28","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"7","key":"854_CR70","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1128\/AAC.49.7.2612-2617.2005","volume":"49","author":"RK Pettit","year":"2005","unstructured":"Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML (2005) Microplate alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 49(7):2612\u20132617. https:\/\/doi.org\/10.1128\/AAC.49.7.2612-2617.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"854_CR71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mib.2016.01.004","volume":"30","author":"OE Petrova","year":"2016","unstructured":"Petrova OE, Sauer K (2016) Escaping the biofilm in more than one way: desorption, detachment or dispersion. Curr Opin Microbiol 30:67\u201378. https:\/\/doi.org\/10.1016\/j.mib.2016.01.004","journal-title":"Curr Opin Microbiol"},{"issue":"1","key":"854_CR72","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","volume":"9","author":"MAE El-Sayed Ahmed","year":"2020","unstructured":"El-Sayed Ahmed MAE, Zhong LL, Shen C, Yang Y, Doi Y, Tian GB (2020) Colistin and its role in the era of antibiotic resistance: an extended review (2000-2019). Emerg Microbes Infect 9(1):868\u2013885. https:\/\/doi.org\/10.1080\/22221751.2020.1754133","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"854_CR73","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.34067\/KID.0006372022","volume":"3","author":"C Westenfelder","year":"2022","unstructured":"Westenfelder C, Gooch A (2022) Heme protein-induced acute kidney injury is caused by disruption of mitochondrial homeostasis in proximal tubular cells. Kidney360 3(12):2140\u20132142. https:\/\/doi.org\/10.34067\/KID.0006372022","journal-title":"Kidney360"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00854-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00430-025-00854-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-025-00854-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:02:49Z","timestamp":1767139369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00430-025-00854-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["854"],"URL":"https:\/\/doi.org\/10.1007\/s00430-025-00854-y","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}},{"value":"The study was approved by the Ethics Committee, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"44"}}